Pivot was created by Carrot Inc., a digital health company on a mission to use mobile technology, behavioral science, and clinical expertise to engage and empower millions of people to quit smoking.
Dr. Utley graduated from Harvard Medical School (’92) and completed his surgical training in otolaryngology-head and neck surgery, as well as facial plastic and reconstructive surgery, at Stanford University Medical Center, where he was subsequently appointed to the faculty as clinical assistant professor of surgery (1992-2003). He has over 25 peer-reviewed publications related to GI, plastic and reconstructive surgery, and otolaryngology.
Prior to starting Carrot, Utley was the first employee and Chief Medical Officer for BARRX Medical (GI endoscopy, acquired by Covidien in 2012) from 2003 to 2014.
Utley has had additional roles as founder, chief medical officer, or member of the board of directors with several start-up medical device companies, including: Somnus Medical Technologies (ENT), Curon Medical (GI), Aetherworks (pulmonary), BAROnova (GI), Freedom-2 (plastics), and CoAlign Innovations (spine), and is the inventor on more than 65 issued U.S. patents and 100 published U.S. patents.
Busy Burr is a cross-industry executive who has made a career creating innovation strategy and operationalizing commercial initiatives in some of the largest, most complex organizations in the world with functional roles spanning finance, marketing and operations.
Most recently, Busy served as Vice President and Chief Innovation Officer at Humana, a $40 billion US healthcare company. In this role, she led a 60+ person team driving the design, build, and adoption of new product platforms in digital health, provider experience, care in the home, and telemedicine.
Before joining Humana in 2015, Busy held leadership positions at Citi Ventures, Gap and eBay, and spent seven years in investment banking at Morgan Stanley and Credit Suisse First Boston, executing IPOs and M&As for companies in the technology space.
Busy is a sought-after speaker and collaborator, and a long-time performing member of the Bay Area improv troupe ‘Subject to Change’. She holds an MBA from Stanford and a BA in Economics from Smith College. She was named one of Silicon Valley’s Women of Influence and has been honored as Frost & Sullivan’s Innovator of the Year.
Dan is a seasoned executive with over 30 years of medical device experience, who has worked in small entrepreneurial companies, as well as Fortune 500 corporations.
Dan recently held C-level positions at DFINE, Inc. as Chief Development Officer until it’s acquisition in July of 2016 and prior to DFINE, as the President & CEO, and member of the Board of Directors, of BaroSense, Inc., a company focused on minimally invasive devices for the treatment of obesity.
Early in his career Dan held various senior management and engineering roles at Rita Medical (successful IPO in August 2000), Johnsons & Johnson Medical Inc., VA (as world-wide Director of R&D), Menlo Care (acquired by J&J in May of 1995) and American Pharmaseal.
Dan currently sits on the Board of Directors for BAROnova, a clinical-stage medical-technology company developing endoscopically-delivered devices for the chronic treatment of obesity.
Dan holds a BSME from California Polytechnic State University and is the author of over 120 patents or patent applications in the medical device field.
Dennis has spent his entire 15-plus-year career in the software industry, in various leadership positions. At Carrot, he oversees Software Engineering, IT, and R&D.
Prior to joining Carrot, Dennis was CTO of Indochino, where he helped scale the company from e-commerce startup to an organization with millions of dollars in monthly revenue and retail stores across North America. He was also previously Director of Technology for CBS Interactive Music Group and the founder of Xian Software, whose clients included CBS and Kobo Books.
Dennis holds a Bachelor of Mathematics, with Honors, in Computer Science from the University of Waterloo.
Rachel has over 17 years of experience developing advanced products for obesity surgery, gastroenterology, and ENT at companies including Xlumena, J&J/Acclarent, and Satiety, Inc.
She has managed development of both products and ancillary services for use by both doctors and patients, including implementation of evidence-based behavior modification programs for patients undergoing bariatric surgery.
Her roles have included strategic marketing including defining user needs for products and guiding development teams to deliver such products, planning and executing product launches, and pursuing reimbursement for medical products and services in U.S. and international payment environments.
Prior to joining the health care industry, Rachel spent five years in healthcare investment banking in San Francisco and New York. Rachel has a degree in Industrial Engineering from Stanford and an MBA from the Wharton School.
Debi has more than 25 years of experience in the health management and wellness industry and has held positions with many of the leading vendors in the space, including StayWell, Health Media, Alere, Healthyroads, and Aon. She has successfully led large client management teams in efforts such as implementation, program strategy, and day-to-day program management. At Carrot, Debi leads the client success team, ensuring customer satisfaction from the sales process through the lifecycle of the client relationship.
Prior to joining Carrot, Debi spent seven years as the senior vice president of program solutions and client strategy at Healthyroads, where she lead a client management team, helped with ongoing product development, managed the consumer health team, and was the executive sponsor for all strategic accounts, including many Fortune 500 groups.
Debi is passionate about employee well-being and has spoken frequently on the topic over the year, including at the Conference Board and the Benefits & Wellness Forum.
Debi holds a bachelor’s in community health education from the University of Northern Iowa and Master’s in wellness from Ball State University.
Kristin oversees marketing for Carrot Inc., in both the business-to-business and consumer arenas. Prior to Carrot, she was VP of marketing at Transcend Insights, a Humana subsidiary where she oversaw marketing, business development, and strategic partnerships.
Recently named as one of Beckers’ “Top 100 Women in Healthcare,” Kristin brings years of experience in the healthcare technology industry, having also led sales and marketing teams at Cerner and Omnicell. She is also a successful entrepreneur, having founded fin-tech company Anachron, which was ultimately sold to ING Bank.
Kristin has an MBA in international finance from the École Supérieure de Commerce de Rennes, France, and a master’s in public administration from Canada’s Carleton University.
Scott has over 16 years of experience as a senior executive in healthcare technology companies that have transformed the distribution of healthcare services and connected millions of consumers with affordable healthcare. At Carrot, Scott oversees sales for our flagship product, Pivot.
Prior to Carrot, Scott led B2C and B2B sales and business development at GoHealth and GetInsured taking both early stage companies to scale. Scott’s efforts have amassed a portfolio of enterprise SaaS clients across government, employer and health plan markets.
Scott has been a frequent speaker and panelist at industry events including Health 2.0, AHIP, Employer Benefit News Expo, The Institute for Healthcare Consumerism, the World Congress Private and Public Exchange Summit, and more. He holds a BA in Marketing from Miami University.
Rajiv has worked in and advised Fortune 500 companies and startups over a 20-year career as a product leader. He brings a blend of strategic and operational expertise to develop products that delight users and achieve results.
Prior to joining Carrot, Rajiv spent more than seven years in digital media as a product management leader at Yahoo, Flickr, and Imgur, where he led a variety of initiatives to drive growth, monetization, and user engagement across both native app and web experiences. He also spent more than three years as a strategy consultant where he advised technology and health care companies on revenue growth, with a focus on product growth and innovation.
Rajiv started his career at Intel Corporation, where he held a variety of engineering and leadership roles in manufacturing semiconductor products. He holds an MBA from Berkeley and BS/MS degrees from Columbia University.
Ha Van T. Le has more than 20 years of experience in budgeting, finance, and accounting for the high-tech industry, with an emphasis in business enterprise solutions and business intelligence.
Throughout her career, Ha Van has participated in multiple acquisitions and two successful initial public offerings: Accuray, Inc. in 2007 and Valicert, Inc. in 2000.
In 2003, Valicert merged with Tumbleweed Communications (NASDAQ: TMWD).
Prior to joining Carrot, Ha Van was the Corporate Controller and VP, Finance and Revenue Operations, at GetInsured, where she played an integral role in the company’s success and growth from 10 to 450 employees.
Ha Van joined Carrot in November of 2017, bringing an in-depth and a wide array of experience and expertise in Finance Operations. As Carrot’s Senior Director, Finance, she is responsible for all aspects of the company’s financial management.
Ha Van holds an MBA from San Jose State University of California and a BS in Managerial Economics from the University of California, Davis.
Dr. Marler received her BS in Neuroscience from UCLA, graduated from the Medical College of Virginia and trained in Radiology at the University of Virginia.
Prior to joining Carrot, she served as the Sr. Director of Global Medical Affairs for BARRX Medical (GI endoscopy, acquired by Covidien in 2012) from 2008 to 2015.
She had increasing roles of responsibility while at BARRX Medical and Covidien, ultimately managing the Medical Affairs team with oversight of the clinical evidence-based strategy, peer relationships, clinical education, and medical writing along with collaborative leadership in clinical trial design, reimbursement and regulatory strategy.